MPI Investment Management’s Pfizer PFE Stock Holding History

MPI Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$2.85M	Buy	+82,946	New	+$2.83M	3.41%	5

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MPI Investment Management's PFE Position: Q4 2017 in Review

MPI Investment Management opened a new position in Pfizer (PFE) in Q4 2017: 82,946 shares worth $2.85M. The stake represents 3.41% of the portfolio and ranks #5 among its holdings.

2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

MPI Investment Management held 82,946 shares of Pfizer worth $2.85M as of Q4 2017.
Pfizer was a new MPI Investment Management position in Q4 2017.
Pfizer made up 3.41% of MPI Investment Management's portfolio in Q4 2017, its #5 holding.
2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on MPI Investment Management's 13F filing for Q4 2017, filed 6 Feb 2018.